%PDF-1.6
%
1 0 obj
<>stream
doi:10.1371/journal.pmed.1003813
Houreratou Barry, Gaudensia Mutua, Hannah Kibuuka, Zacchaeus Anywaine, Sodiomon B. Sirima, Nicolas Meda, Omu Anzala, Serge Eholie, Christine Bétard, Laura Richert, Christine Lacabaratz, M. Juliana McElrath, Stephen De Rosa, Kristen W. Cohen, Georgi Shukarev, Cynthia Robinson, Auguste Gaddah, Dirk Heerwegh, Viki Bockstal, Kerstin Luhn, Maarten Leyssen, Macaya Douoguih, Rodolphe Thiébaut, the EBL2002 Study group
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa
10.1371/journal.pmed.1003813
http://dx.doi.org/10.1371/journal.pmed.1003813
2021-10-29
false
10.1371/journal.pmed.1003813
www.plosmedicine.org
10.1371/journal.pmed.1003813
2021-10-29
false
www.plosmedicine.org
endstream
endobj
2 0 obj
<>
endobj
5 0 obj
<>/ProcSet 13 0 R/XObject<>>>
endobj
6 0 obj
[15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R]
endobj
15 0 obj
<>/Border[0 0 0]>>
endobj
21 0 obj
<>
endobj
16 0 obj
<>/Border[0 0 0]>>
endobj
22 0 obj
<>
endobj
17 0 obj
<>/Border[0 0 0]>>
endobj
23 0 obj
<>
endobj
18 0 obj
<>/Border[0 0 0]>>
endobj
24 0 obj
<>
endobj
19 0 obj
<>/Border[0 0 0]>>
endobj
25 0 obj
<>
endobj
20 0 obj
<>/Border[0 0 0]>>
endobj
26 0 obj
<>
endobj
3 0 obj
<>stream
x\YsHr~b[fC.uJMؖnLwr/3+
H:
{$(T嗉(88N8>NxuTT%iӨixw]qe%?U2z
oDZQx:2eNk1VX6;N2_XQ]5veytsg
M((nqGM]_yQz\UT|u89:b'/cgvoxÚ2Mܿ_Um?vt=8@yW|-lܵ>?YY"wݶ)h{n>l2+;kۮ^ktV;+DqC?_DE^}uZꒇ_ʋ;,<%Q^.{}?nXGuW&H$Ͷ_{7D/c_Ba~dn!Gl˭sٯrC9߶~(
8;NPx⽪o̲"j&a.R&uؗ[kwMlNx!lo߯M2`kt1.R=f;oT<Ҝ4sYZE#(:A)nֳTڈ7N!z;,r,L(a1`*V>ۺW5A8)Ҩlu\]4t.X{'gL0A`/c| d22 4x2H YgO8F)%)z]n)".DѸ +nbETƔ9DAR5Rb{Y a_yv륋qWr1հٹV9H {!)Ay9
HGimgmWf4'$g,(sB,<"+նЉK &nXR5,tcC_9eFUU(
T Rga.ASC5+`CnKKr7]h7/yTgSmu.{N gݾ[s֗o݆y-%/݉J
t(q;'"䥑l/f%{D1@h'h|"?^wêo9 6.vTjHsrˈT>{j߈6>7ߋ*SUU9@hfyIR
Ԁ0pv[4 3C#U' ]XN4TꝬ'0)&潋